EP1631289A4 - Composes de benzamide anti-vih - Google Patents

Composes de benzamide anti-vih

Info

Publication number
EP1631289A4
EP1631289A4 EP04752748A EP04752748A EP1631289A4 EP 1631289 A4 EP1631289 A4 EP 1631289A4 EP 04752748 A EP04752748 A EP 04752748A EP 04752748 A EP04752748 A EP 04752748A EP 1631289 A4 EP1631289 A4 EP 1631289A4
Authority
EP
European Patent Office
Prior art keywords
hiv
benzamide compounds
benzamide
compounds
hiv benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04752748A
Other languages
German (de)
English (en)
Other versions
EP1631289A2 (fr
Inventor
Vassilios Papadopoulos
Janet Greeson
Laurent Lecanu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Samaritan Pharmaceuticals Inc
Original Assignee
Georgetown University
Samaritan Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University, Samaritan Pharmaceuticals Inc filed Critical Georgetown University
Publication of EP1631289A2 publication Critical patent/EP1631289A2/fr
Publication of EP1631289A4 publication Critical patent/EP1631289A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP04752748A 2003-06-02 2004-05-20 Composes de benzamide anti-vih Withdrawn EP1631289A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US47496403P 2003-06-02 2003-06-02
US47564203P 2003-06-04 2003-06-04
US47864803P 2003-08-01 2003-08-01
US56463604P 2004-04-22 2004-04-22
PCT/US2004/015791 WO2004108076A2 (fr) 2003-06-02 2004-05-20 Composes de benzamide anti-vih

Publications (2)

Publication Number Publication Date
EP1631289A2 EP1631289A2 (fr) 2006-03-08
EP1631289A4 true EP1631289A4 (fr) 2010-06-02

Family

ID=33514877

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04752748A Withdrawn EP1631289A4 (fr) 2003-06-02 2004-05-20 Composes de benzamide anti-vih

Country Status (5)

Country Link
EP (1) EP1631289A4 (fr)
JP (1) JP2006526633A (fr)
AU (1) AU2004244982A1 (fr)
CA (1) CA2527211A1 (fr)
WO (1) WO2004108076A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005016276A2 (fr) * 2003-08-05 2005-02-24 Samaritan Pharmaceuticals Inc. Ligand du recepteur sigma-1 presentant des proprietes d'inhibition de l'acetylcholinesterase
JP2007531792A (ja) * 2004-04-05 2007-11-08 サマリタン，ファーマスーティカルス，インク． 抗ｈｉｖキヌクリジン化合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001096304A1 (fr) * 2000-06-13 2001-12-20 Eli Lilly And Company Inhibiteurs de la protease serine
WO2002032871A2 (fr) * 2000-10-17 2002-04-25 The Procter & Gamble Company Composes acycliques et methodes de traitement de pharmacoresistance multiple
WO2005000205A2 (fr) * 2003-06-02 2005-01-06 Samaritan Pharmaceuticals, Inc. Methodes et compositions permettant de moduler les taux de cortisol serique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1279843A (en) * 1969-05-23 1972-06-28 Science Union & Cie Benzamidoethyl-piperazines and process for their preparation
JP2769578B2 (ja) * 1989-10-13 1998-06-25 大塚製薬株式会社 バソプレシン拮抗剤
DE4302485A1 (de) * 1993-01-29 1994-08-04 Merck Patent Gmbh Piperazinderivate
IL125658A0 (en) * 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6339087B1 (en) * 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001096304A1 (fr) * 2000-06-13 2001-12-20 Eli Lilly And Company Inhibiteurs de la protease serine
WO2002032871A2 (fr) * 2000-10-17 2002-04-25 The Procter & Gamble Company Composes acycliques et methodes de traitement de pharmacoresistance multiple
WO2005000205A2 (fr) * 2003-06-02 2005-01-06 Samaritan Pharmaceuticals, Inc. Methodes et compositions permettant de moduler les taux de cortisol serique

Also Published As

Publication number Publication date
WO2004108076A2 (fr) 2004-12-16
WO2004108076A3 (fr) 2005-12-29
EP1631289A2 (fr) 2006-03-08
JP2006526633A (ja) 2006-11-24
CA2527211A1 (fr) 2004-12-16
AU2004244982A1 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
BR0313322B1 (pt) escova de dentes
DK1563100T3 (da) Fortrængningssandwich-immuno-PCR
DE602004006644D1 (de) Zäh-elastische säure
EP1477118A4 (fr) Ultrasonographe
EP1500371A4 (fr) Echographe
ATA1782003A (de) Lösbare schnappverbindung
DE60328353D1 (de) Schwungmasse
DE60315063D1 (de) Elektrokontaktelement
DK1492934T3 (da) Dørenhed
DE602004004176D1 (de) Arbeitsgerät
DE502004006636D1 (de) Verbindungselement
EP1500370A4 (fr) Ultrasonographe
FI20022005A7 (fi) Liitoskappale
BR0311793B1 (pt) Projétil de neblina
DE60236534D1 (de) Verbesserte herbizidzusammensetzung
EP1377281A4 (fr) Composes de taurine
DE50302582D1 (de) Schnapp-Kugelzapfen
FR2861758B1 (fr) Element de caniveau
ITMI20042063A1 (it) Giunto
EP1658301A4 (fr) Composes n-desmethyl-11-desoxyerythromycine-n-substitues
ATE357603T1 (de) Befestigungsanordnung
ATA9832002A (de) Abstandselement
FR2844817B1 (fr) Element de coffrage
AT500197B1 (de) Kreiselschwader
FR2851150B3 (fr) Structure de grille-pain

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051214

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL HR LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100504

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 31/18 20060101ALI20100427BHEP

Ipc: A61P 31/00 20060101ALI20100427BHEP

Ipc: A61K 31/33 20060101ALI20100427BHEP

Ipc: A61K 31/497 20060101AFI20060105BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100823